Fogarty HIV Research Training Program (Mozambique)

描述（由申请人提供）：我们建议在莫桑比克建立匹兹堡大学（皮特）艾滋病毒研究培训计划（皮特HRTP）。该方案的目的是建立莫桑比克天主教大学的研究能力， 贝拉，用于开展艾滋病毒临床试验。该计划是皮特艾滋病国际培训和研究计划（AITRP）的延伸，该计划成立于1998年，自2009年以来一直在UCM建立研究能力。此前，皮特艾滋病研究和治疗方案为巴西的研究能力建设作出了重大贡献，以在里约热内卢和圣保罗建立艾滋病毒疫苗试验网络。皮特HRTP将由流行病学和医学教授Lee Harrison博士指导，他也是皮特AITRP的主任。在流行病学和生物统计学、实验室科学、行为科学以及其他与临床试验相关的领域，将提供广泛的非学位和学位培训机会。参加培训的地点有皮特、巴西里约热内卢联邦大学、南非开普敦斯泰伦博斯大学和莫桑比克曼希亚的曼希亚卫生研究中心。该计划包括一个多学科小组的经验丰富的导师和良好的培训机会，在每个网站。将国际法学家联合会、国际法学家联合会和国际科学院联合会包括在内，为“南南”培训提供了大量机会。学员将有机会获得参与机构的所有相关资源。衡量项目成功的一个关键指标是UCM在五年资助期结束前参与艾滋病毒临床试验。

DESCRIPTION (provided by applicant): We propose to establish the University of Pittsburgh (Pitt) HIV Research Training Program in Mozambique (Pitt HRTP). The purpose of the program is to build research capacity at the Catholic University of Mozambique, located in the port city of Beira, for the conduct of HIV clinical trials. This program is an extension of the Pitt AIDS International Training and Research Program (AITRP), which was established in 1998 and has been building research capacity at UCM since 2009. Previously, the Pitt AITRP contributed substantially to building research capacity in Brazil for the development of HIV Vaccine Trials Network (HVTN) sites in Rio de Janeiro and Sjo Paulo. The Pitt HRTP will be directed by Dr. Lee Harrison, Professor of Epidemiology and Medicine, who was also the Director of the Pitt AITRP. A broad array of non- degree and degree training opportunities will be available in epidemiology and biostatistics, laboratory sciences, behavioral sciences, and other fields relevant to clinical trials. Participating training sites are Pitt; the Federal University of Rio d Janeiro (UFRJ), Brazil; the University of Stellenbosch (SU), Cape Town, South Africa; and the Manhija Health Research Center (CISM), Manhija, Mozambique. The program includes a multidisciplinary group of experienced mentors and excellent training opportunities at each site. The inclusion of UFRJ, SU, and CISM provides substantial opportunities for "south-to-south" training. Trainees will have access to all of the relevant resources of the participating institutions. A key measure of program success will be the participation of UCM in HIV clinical trials by the end of the five-year funding period.